Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial to Assess the Activity of Ketoconazole Plus GM-CSF in Patients With Prostate Cancer Progressive After Androgen Deprivation

NCT00309894 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00309894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00309894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial to Assess the Activity of Ketoconazole Plus GM-CSF in Patients With Prostate Cancer Progressive After Androgen Deprivation
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2004
Completion date
December 31, 2007
Enrollment
49 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer